Encycle Therapeutics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 6

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $80M

Encycle Therapeutics General Information

Description

Developer of drugs designed to exploit a novel synthetic method to generate drug-like cyclic peptides. The company's drugs are generated by several scaffolds that are membrane-permeable and orally bioavailable products thereby, enabling patients to get cured of inflammatory bowel disease and other inflammatory disorders.

Contact Information

Website
www.encycletherapeutics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 101 College Street
  • Suite 314
  • Toronto, Ontario M5G 1L7
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Zealand Pharma
Vertical(s)
Life Sciences
Corporate Office
  • 101 College Street
  • Suite 314
  • Toronto, Ontario M5G 1L7
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Encycle Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 22-Oct-2019 $80M Completed Generating Revenue
5. Corporate 01-Nov-2017 Completed Generating Revenue
4. Early Stage VC 30-Sep-2015 Completed Startup
3. Early Stage VC 16-Jun-2015 Completed Startup
2. Grant 17-Nov-2014 $2.5M Completed Startup
1. Early Stage VC 11-Nov-2014 $2.5M $2.5M Completed Startup
To view Encycle Therapeutics’s complete valuation and funding history, request access »

Encycle Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of drugs designed to exploit a novel synthetic method to generate drug-like cyclic peptides. The company's dru
Drug Discovery
Toronto, Canada
6 As of 2015

Vienna, Austria
 

Montreal, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Encycle Therapeutics Competitors (17)

One of Encycle Therapeutics’s 17 competitors is Apeptico, a Venture Capital-Backed company based in Vienna, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Apeptico Venture Capital-Backed Vienna, Austria
Cyclenium Pharma Corporate Backed or Acquired Montreal, Canada
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
Rein Therapeutics Formerly VC-backed Austin, TX
Oncorus Formerly VC-backed Andover, MA
You’re viewing 5 of 17 competitors. Get the full list »

Encycle Therapeutics Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Encycle Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2967750-A1 Solid phase synthesis of cyclic amino acid molecules Inactive 19-Nov-2014
EP-3221335-A1 Solid phase synthesis of cyclic amino acid molecules Inactive 19-Nov-2014
EP-3221335-A4 Solid phase synthesis of cyclic amino acid molecules Inactive 19-Nov-2014
US-20170320908-A1 Solid phase synthesis of cyclic amino acid molecules Inactive 19-Nov-2014 C07K1/1077

Encycle Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Encycle Therapeutics Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accel-Rx Accelerator/Incubator Minority
BDC Capital Growth/Expansion Minority
CQDM Other Minority
MaRS Investment Accelerator Fund Venture Capital Minority
Merck & Co. Corporation
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Encycle Therapeutics FAQs

  • When was Encycle Therapeutics founded?

    Encycle Therapeutics was founded in 2012.

  • Where is Encycle Therapeutics headquartered?

    Encycle Therapeutics is headquartered in Toronto, Canada.

  • What is the size of Encycle Therapeutics?

    Encycle Therapeutics has 6 total employees.

  • What industry is Encycle Therapeutics in?

    Encycle Therapeutics’s primary industry is Drug Discovery.

  • Is Encycle Therapeutics a private or public company?

    Encycle Therapeutics is a Private company.

  • What is the current valuation of Encycle Therapeutics?

    The current valuation of Encycle Therapeutics is .

  • What is Encycle Therapeutics’s current revenue?

    The current revenue for Encycle Therapeutics is .

  • How much funding has Encycle Therapeutics raised over time?

    Encycle Therapeutics has raised $5.99M.

  • Who are Encycle Therapeutics’s investors?

    Accel-Rx, BDC Capital, CQDM, MaRS Investment Accelerator Fund, and Merck & Co. are 5 of 9 investors who have invested in Encycle Therapeutics.

  • Who are Encycle Therapeutics’s competitors?

    Apeptico, Cyclenium Pharma, Alnylam Pharmaceuticals, Rein Therapeutics, and Oncorus are some of the 17 competitors of Encycle Therapeutics.

  • When was Encycle Therapeutics acquired?

    Encycle Therapeutics was acquired on 22-Oct-2019.

  • Who acquired Encycle Therapeutics?

    Encycle Therapeutics was acquired by Zealand Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »